Table 7.
Expression density of acetylcholine receptor (AChR) on CD14+ monocytes, CD3+ T-cells, and CD19+ B-cells
| Controls | Diabetic HD | Nondiabetic HD | All HD | |
|---|---|---|---|---|
| AChR/CD14+ Monocytes (MFI) | 7.0 [1.8] | 15.4 [6.9]* | 15.3 [3.3]** | 15.4 [5.2] |
| AChR/CD3+ T-Lymphocytes (MFI) | 14.3 [8.3] | 15.9 [5.3] | 11.7 [5.3] | 13.1 [5.9] |
| AChR/CD19+ B- Lymphocytes (MFI) | 10.8 [3.0] | 13.3 [5.3] | 14.3 [8.4] | 14.2 [5.7] |
* = p < 0.05 vs. controls; **p < 0.01 vs. controls by Kruskal-Wallis and Dunn’s test. Statistical tests were done for the three groups controls, diabetic and nondiabetic patients. The column “all HD” remained untested. MFI: Mean fluorescence intensity